Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (81-90 of 288) with videos related to

Pageof 29
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2002
Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophyLivio Luzi, Gianluca Perseghin, Giuseppe Tambussi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patientsNicola Gianotti, Laura Galli, Enzo Boeri, et al.
Current HIV/AIDS Reports|September 3, 2020
Relapse of Symptomatic Cerebrospinal Fluid HIV EscapeFrancesca Ferretti, Valentina De Zan, Simonetta Gerevini, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 22, 2014
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
BMC Infectious Diseases|December 16, 2011
Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapyFrancesca Ferretti, Antonio Boschini, Cristiana Iabichino, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 7, 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceUmberto Restelli, Massimo Andreoni, Andrea Antinori, et al.
AIDS (London, England)|May 29, 2004
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendationsBonaventura Clotet, François Raffi, David Cooper, et al.
AIDS (London, England)|May 21, 2005
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trialKeikawus Arastéh, Nathan Clumeck, Anton Pozniak, et al.
The New Microbiologica|October 11, 2008
Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patientsNicola Gianotti, Myriam Maillard, Giovanni Gaiera, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravirFilippo Canducci, Elisa Rita Ceresola, Diego Saita, et al.
Pageof 29

Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2002
Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophyLivio Luzi, Gianluca Perseghin, Giuseppe Tambussi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patientsNicola Gianotti, Laura Galli, Enzo Boeri, et al.
Current HIV/AIDS Reports|September 3, 2020
Relapse of Symptomatic Cerebrospinal Fluid HIV EscapeFrancesca Ferretti, Valentina De Zan, Simonetta Gerevini, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 22, 2014
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
BMC Infectious Diseases|December 16, 2011
Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapyFrancesca Ferretti, Antonio Boschini, Cristiana Iabichino, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 7, 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceUmberto Restelli, Massimo Andreoni, Andrea Antinori, et al.
AIDS (London, England)|May 29, 2004
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendationsBonaventura Clotet, François Raffi, David Cooper, et al.
AIDS (London, England)|May 21, 2005
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trialKeikawus Arastéh, Nathan Clumeck, Anton Pozniak, et al.
The New Microbiologica|October 11, 2008
Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patientsNicola Gianotti, Myriam Maillard, Giovanni Gaiera, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravirFilippo Canducci, Elisa Rita Ceresola, Diego Saita, et al.
Pageof 29